English
General description
Use Discovery® C18 for any method that specifies a C18. The exceptional peak shape, reproducibility, and stability make it the column of choice for all C18 methods from demanding to routine.
Application
A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies.: This paper describes the use of the Discovery® C18 HPLC Column in developing a stability-indicating method for the COVID-19 therapeutic, molnupiravir, emphasizing its critical role in supporting pandemic response through advanced drug formulation and analysis (Recber et al., 2022).
Features of assay and decomposition dynamics of 2-methoxy-4-(1-propenyl)hydroxybenzene in biological material.: Demonstrates the versatility of the Discovery® C18 HPLC Column in forensic science, particularly in the analysis and decomposition studies of complex organic compounds within biological samples (Chernova et al., 2022).
Features and Benefits
Excellent reproducibility
Exceptional peak shape for basic and acidic analytes
Stable, low-bleed LC-MS separations
Separation of peptides and small proteins
Lower hydrophobicity than many comparable C18 columns, providing faster analysis
Other Notes
Discover LiChropur reagents ideal for HPLC or LC-MS analysis
Legal Information
Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany
